Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.
Description
Description
COMPOSITION: Each capsules contains Palbociclib 125 mg
INDICATION: Indications for use PALBOCICLIB is indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative, locally advanced or metastatic breast cancer: – in combination with an aromatase inhibitor; – in combination with fulvestrant in women previously receiving endocrine therapy. In pre-or perimenopausal women, endocrine therapy should be combined with aluteinization. Hormone Releasing Hormone (LHRH) agonists.
PACKING: 21 Capsules / Bottle
Download Product PDF Attachment